Journal of Health Care Compliance
Looking Ahead: DOJ Enforcement Priorities in 2025
November – December 2024
In 2024, the Department of Justice (DOJ) continued to emerge from a pandemic lull and return to vigorous enforcement of the False Claims Act (FCA) — indeed in February, DOJ announced that it had issued a record 1,504 civil investigative demands in fiscal year 2023, and its current activity levels suggest another record-breaking year. In 2025, the healthcare industry can expect that DOJ will continue to prioritize investigating alleged fraud, waste, and abuse in the industry, with particular attention paid to private equity investment, the Anti-Kickback Statute (AKS), pandemic relief fraud, and cyber fraud.
Contacts
Related Blogs
Capabilities
Suggested News & Insights
$14.1 Million FCA Settlement Underscores Medicare Advantage Coding ScrutinyAugust 6, 2026New York Ethics Opinion Addresses Ethical Limits on Attorney Participation in Whistleblower InvestigationsJuly 30, 2026Laboratory, Owners, and Investors Settle COVID-19 Testing Fraud Allegations for $24 MillionJuly 27, 2026DOJ Releases FOCUS Questionnaire to Assist in Evaluating Qui Tams Filed by Data MinersJuly 20, 2026June DOJ/SBA FCA Settlement Highlights Continued Focus on Contractor ComplianceJuly 15, 2026Texas Supreme Court Imposes Materiality Requirement on Texas Healthcare Fraud Omissions ClaimsJuly 7, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
